The Aims Of The Patvocates Network

The aims of the Patvocates Network

VJHemOnc – Video Journal of Hematology & HemOnc

The role of the Patvocates Network in promoting patient advocacy

The Patients' Channel

Educating for excellence: educating patients and advocates

The importance of patient advocacy tracks at congresses

VJHemOnc – Video Journal of Hematology & HemOnc

IMI Impact on Patient involvement- Jan Geissler

The Innovative Health Initiative

What is Patient Advocates for Lupus Studies (PALS)?

Lupus Research Alliance

Bladder Cancer Advocacy Network Turns 15

Bladder Cancer Advocacy Network

Jan Geissler from Patvocates on the Patient Engagement Matrix Survey (Part 1)

Patient Focused Medicines Development (PFMD)

Building Bridges: Patient Advocacy Groups Can Be Vital Partners in Clinical Research Trials

Rho

Part Two: Understanding Patient Communities is Vital for Clinical Trial Education

Jan Geissler from Patvocates on PFMD and the Reasonable Legal Agreements Initiatives

Patient Focused Medicines Development (PFMD)

I am DIA with Jan Geissler, Managing Director at Patvocates

DIA

Jan Geissler - Patient involvement in clinical research

Myeloma Patients Europe

Why I am a Patient Advocate - Lisa Mitchell | National Patient Advocate Foundation

NPAF National Patient Advocate Foundation

Understanding Common MPN Clinical Trial Terms

Patient Empowerment Network

The need for patient advocates to attend major congresses such as EBMT

VJHemOnc – Video Journal of Hematology & HemOnc

The evolution of patient advocacy

VJHemOnc – Video Journal of Hematology & HemOnc

How the plan, medical network and doctor work together

An MPN Expert Defines Clinical Trial Types

Patient Empowerment Network

Role of patient advocates in a European Reference Network